Late Stage Lung Cancer
晚期肺癌
基本信息
- 批准号:8340005
- 负责人:
- 金额:$ 53.35万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2009
- 资助国家:美国
- 起止时间:2009-09-30 至 2014-08-31
- 项目状态:已结题
- 来源:
- 关键词:AccountingActivities of Daily LivingAdvanced Practice NurseAgeAnxietyBody Weight decreasedCancer PatientCaregiversCaringCause of DeathCharacteristicsCognitionComorbidityDataDiagnosisDietitianDiseaseDistressEmotionalEnrollmentEthnic OriginFamilyFamily CaregiverGenderGeriatric AssessmentGoalsHealthcareHospitalsIndividualInstructionInterventionKarnofsky Performance StatusLinkMalignant NeoplasmsMalignant neoplasm of lungMeasuresMemoryMental DepressionMeta-AnalysisMethodsModelingNon-Small-Cell Lung CarcinomaNutritional statusOutcomePalliative CarePatientsPerformancePhasePopulationPsychologistPublic HealthQuality of lifeResearchResearch PersonnelSeaServicesSocial WorkSocial supportStagingStructureSubgroupSupportive careSymptomsSystemTestingTimeTreatment FactorUnited StatesUnresectableVisitWorkbasecancer carecancer palliative treatmentcaregivingcostdesignfallsfunctional statusgroup interventionimprovedinstrumental activity of daily livinginterdisciplinary collaborationolder patientphysical conditioningprimary outcomeprogramsprospectivepsychoeducational interventionpsychological distresspsychosocialsatisfactionsocialsymptom managementtreatment as usual
项目摘要
PROJECT SUMMARY (Sea instructions):
Project 2: Late Stage Lung Cancer focuses on Stages Illb-IV unresectable lung cancer within a program project with central themes related to palliative care, quality of life (QOL), and symptom management. This project focuses on Late Stage Lung Cancer, a population who have decreased survival and high QOL and symptom concerns. The aims of the research are:
Aim1: Test the effects of the Palliative Care Intervention (PCI) on overall QOL and psychological distress for patients with Late (Stage Illb-IV) non-resectable NSCLC compared to a group receiving usual care.
Aim 2: Compare symptom control in the PCI group versus the usual care group in Late Stage NSCLC.
Aim 3: Compare geriatric assessment outcomes (OARS Instrumental Activities of Daily Living, MOS Activities of Daily Living, MOS Social Activities Limitation Scale, Hospital Anxiety and Depression Scale scores, and the Karnofsky Performance Scale) in the PCI group versus the usual care group.
Aim 4: Test the effects of the PCI on resource use as compared to the usual care group.
Aim 5: Identify subgroups of patients who benefit most from the PCI in relation to sociodemographic characteristics, treatment factors, and geriatric assessment predictors at the 12 week primary end point.
A two-group, prospective sequential, quasi-experimental, tandem enrollment design (N=326) will be used for this project, in which the usual care group is accrued and followed during Phase 1 and the intervention group is accrued and followed during Phase 2.
The proposed PCI intervention combines pre-treatment assessment and goal setting through the collaboration of an interdisciplinary team. The Palliative Care Intervention is based on pilot work completed from 2005-2007 by the investigators documenting needs of lung cancer patients and testing the intervention.
This project has great significance to public health given the significant numbers of people diagnosed with lung cancer and the associated individual and societal costs.
项目摘要(海上说明):
项目2:晚期肺癌重点介绍一个计划项目中不可切除的肺癌,该项目的中心主题与姑息治疗,生活质量(QOL)和症状管理有关。该项目的重点是晚期肺癌,肺癌是一种人群,降低了生存率,高质量和症状问题。研究的目的是:
AIM1:与接受常规护理的组相比,对患有晚期(阶段IV-IV)不可切除的NSCLC患者的姑息治疗干预(PCI)对整体QOL和心理困扰的影响。
AIM 2:比较PCI组的症状控制与晚期NSCLC的常规护理组。
AIM 3:比较PCI组与通常的护理小组的老年评估结果(日常生活的OARS工具活动,日常生活活动,MOS社交活动限制量表,医院焦虑和抑郁量表得分以及Karnofsky绩效量表)。
AIM 4:与通常的护理组相比,测试PCI对资源使用的影响。
目标5:确定从PCI中受益于社会人口统计学特征,治疗因素和老年评估预测指标的患者的亚组。
该项目将使用两组,前瞻性,准实验性,串联入学设计(n = 326),在该项目中,通常在第1阶段进行了通常的护理组并遵循,并且在第2阶段进行了干预组并遵循。
拟议的PCI干预通过跨学科团队的合作结合了预处理评估和目标设定。姑息治疗干预措施基于2005 - 2007年从2005年至2007年完成的试点工作,记录了肺癌患者需求并测试干预措施。
鉴于大量被诊断为肺癌以及相关的个人和社会成本的人,该项目对公共卫生具有重要意义。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ROBERT Alan FIGLIN其他文献
ROBERT Alan FIGLIN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ROBERT Alan FIGLIN', 18)}}的其他基金
Phase II Trial of Recombinant Human Granulocyte Macrop
重组人粒细胞Macrop的II期试验
- 批准号:
7043101 - 财政年份:2003
- 资助金额:
$ 53.35万 - 项目类别:
SAFETY AND BIOLOGIC ACTIVITY OF RHU GM-CSF AND RHU IL4 TO TREAT CANCER
RHU GM-CSF 和 RHU IL4 治疗癌症的安全性和生物活性
- 批准号:
6412126 - 财政年份:2000
- 资助金额:
$ 53.35万 - 项目类别:
ANTIGEN SPECIFIC IMMUNOTHERAPY IN MUC 1 POSITIVE PATIENTS
MUC 1 阳性患者的抗原特异性免疫治疗
- 批准号:
6412107 - 财政年份:2000
- 资助金额:
$ 53.35万 - 项目类别:
ANTIGEN SPECIFIC IMMUNOTHERAPY IN MUC 1 POSITIVE PATIENTS
MUC 1 阳性患者的抗原特异性免疫治疗
- 批准号:
6452009 - 财政年份:1999
- 资助金额:
$ 53.35万 - 项目类别:
SAFETY AND BIOLOGIC ACTIVITY OF RHU GM-CSF AND RHU IL4 TO TREAT CANCER
RHU GM-CSF 和 RHU IL4 治疗癌症的安全性和生物活性
- 批准号:
6452020 - 财政年份:1999
- 资助金额:
$ 53.35万 - 项目类别:
相似国自然基金
城市夜间日常生活区的演进过程、活力机制与更新治理路径研究
- 批准号:52378053
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
川江流域山地旧城滨水区日常生活空间与地形关系演进及其当代传承研究:以重庆为例(1891-2004)
- 批准号:52308006
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
中国城市-乡村生活方式移民的乡村意象与日常生活研究
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
中国城市-乡村生活方式移民的乡村意象与日常生活研究
- 批准号:42201250
- 批准年份:2022
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
融合媒介环境学视角的日常生活空间体验研究
- 批准号:42171221
- 批准年份:2021
- 资助金额:47 万元
- 项目类别:面上项目
相似海外基金
Palliative Care at Home for Patients with Dementia
痴呆症患者的居家姑息治疗
- 批准号:
10688048 - 财政年份:2022
- 资助金额:
$ 53.35万 - 项目类别:
Palliative Care at Home for Patients with Dementia
痴呆症患者的居家姑息治疗
- 批准号:
10525038 - 财政年份:2022
- 资助金额:
$ 53.35万 - 项目类别:
The Neural Basis of Apathy in Frontotemporal Degeneration: A Longitudinal Study
额颞叶退化中冷漠的神经基础:一项纵向研究
- 批准号:
8647992 - 财政年份:2014
- 资助金额:
$ 53.35万 - 项目类别:
Palliative Care for Quality of Life and Symptom Concerns in Lung Cancer
姑息治疗对肺癌患者生活质量和症状的关注
- 批准号:
8328995 - 财政年份:2009
- 资助金额:
$ 53.35万 - 项目类别:
Palliative Care for Quality of Life and Symptom Concerns in Lung Cancer
姑息治疗对肺癌患者生活质量和症状的关注
- 批准号:
8546986 - 财政年份:2009
- 资助金额:
$ 53.35万 - 项目类别: